<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The renin-angiotensin system is involved in the development of <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We studied the association between the M235T polymorphism of the angiotensinogen gene (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AGT</z:e>) and the C573T polymorphism of the <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> type 1 receptor (AT1R) and blood pressure, carotid <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and cerebrovascular disease </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We genotyped over 6000 subjects from the Rotterdam Study and more than 1000 subjects from the Rotterdam Scan Study </plain></SENT>
<SENT sid="3" pm="."><plain>We used logistic regression and univariate analyses, adjusting for age and sex with, for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AGT</z:e>, the MM and, for AT1R, the TT genotype as reference </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: We found that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AGT</z:e>-235T increased systolic (p for trend = 0.03) and diastolic blood pressure (p for trend = 0.04) </plain></SENT>
<SENT sid="5" pm="."><plain>The prevalence of carotid plaques was increased 1.25-fold (95% CI 1.02-1.52) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AGT</z:e>-TT carriers </plain></SENT>
<SENT sid="6" pm="."><plain>There was a significant increase in mean volume deep subcortical white matter lesions (WML) for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AGT</z:e>-TT carriers (1.78 ml vs 1.09 ml in the reference group; p = 0.008) </plain></SENT>
<SENT sid="7" pm="."><plain>A significant interaction was found between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AGT</z:e> and AT1R, further increasing the effect on periventricular and subtotal WML (p for interaction = 0.02) </plain></SENT>
<SENT sid="8" pm="."><plain>We found a non-significant increased risk of silent <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AGT</z:e>-TT carriers and AT1R-CC carriers, but no effect on <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: We found an association between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AGT</z:e> and blood pressure, <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and WML </plain></SENT>
<SENT sid="10" pm="."><plain>Also, we found synergistic effects between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AGT</z:e> and AT1R on the development of WML </plain></SENT>
<SENT sid="11" pm="."><plain>These findings raise the question of whether the renin-angiotensin system may be a therapeutic target for the prevention of cerebral white matter pathology </plain></SENT>
</text></document>